Global Sevoflurane Anesthesia Market Research Report 2022

Sevoflurane is a fluorine-containing inhaled anesthetic.The minimum alveolar concentration (MAC) was 0.66% in the mixture of oxygen and nitrous oxide.1.7% in pure oxygen;Similar to the enflurane, 1/2 as much as the flurane.The lethal concentration (LC50)/MAC was higher than that of enflurane.The induction time was shorter than that of enflurane and flurane.
Due to the COVID-19 pandemic, the global Sevoflurane Anesthesia market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Sevoflurane Anesthesia market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Sevoflurane Anesthesia landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
120ml accounting for % of the Sevoflurane Anesthesia global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While For Human Use segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Sevoflurane Anesthesia include Abbott, Baxter, Maruishi Pharmaceutical, Jiangsu Hengrui, Hebei Yipin Pharmaceutical and Lunan, etc. In terms of revenue, the global 3 largest players have a % market share of Sevoflurane Anesthesia in 2021.
This report focuses on Sevoflurane Anesthesia volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Sevoflurane Anesthesia market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Sevoflurane Anesthesia Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
by Capacity
120ml
250ml
by Management category
Original Drugs
Generic Drugs
Segment by Application
For Human Use
For Animal Use
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Abbott
Baxter
Maruishi Pharmaceutical
Jiangsu Hengrui
Hebei Yipin Pharmaceutical
Lunan